Skip to content

LED therapy in muscle fatigue

LED therapy in muscle fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4253s4
Enrollment
Unknown
Registered
2015-03-13
Start date
2013-05-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia, Muscle fatigue

Interventions

Thirty volunteers between 60 and 70 years will participate in a double-blind, placebo-controlled study, randomized in two groups: LED Group (LG
n = 15), the irradiated group will receive phototherapy with a light-emitting diode LED in 638 nm, 150 mW, 4.5 J / point, 18 J total in four equidistant points in the dominant forearm, on the belly of
Other
E02.774

Sponsors

Universidade Camilo Castelo Branco
Lead Sponsor
Areolino Pena Matos
Collaborator

Eligibility

Sex/Gender
Female
Age
60 Years to 70 Years

Inclusion criteria

Inclusion criteria: Women between 60 and 70 years of age; non-athletes; with BMI between 18.5 and 29.99 Kg/m2 who agreed to take part in the approved study after signing the consent form.

Exclusion criteria

Exclusion criteria: Previous lower limb and cervical surgery; degenerative systemic diseases; regular use of muscle relaxants or use at least 3 days before the test; rhabdomyolysis; neuromuscular disease, myasthenia gravis; polymyositis; asymptomatic degenerative or inflammatory joint disease in the hands, wrists, and elbows; tendinitis or tenosynovitis of the wrist extensors or flexors and fingers.

Design outcomes

Primary

MeasureTime frame
Increase or maintenance of muscle grip strength; measured by hydraulic dynamometry in group treated with LED, verified by at least 1 kg force strength variation, before and after muscle fatigue induction

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactAreolino Matos

Universidade Camilo Castelo Branco

areolino.matos@gmail.com+55(96)30813114

Outcome results

None listed

Source: REBEC (via WHO ICTRP)